2026 Humana Basic Rx Plan (PDP) formulary (drug list)
Contract S5884, plan 146 · Arizona · 2,972 drugs on file · formulary ID 00026399. Each drug links to its cost in every CMS PDP Region 28 plan.
149 drugs starting with E.
| Drug name | Tier | 30-day preferred pharmacy | 90-day mail order | Usage management |
|---|---|---|---|---|
| EDURANT 25 mg Tablet, Film CoatedRilpivirine Hydrochloride | 5Specialty Tier | 25% | N/A |
|
| EDURANT PED 2.5 mg Tablet, For SuspensionRilpivirine Hydrochloride | 5Specialty Tier | 25% | N/A |
|
| EFAVIRENZ 600 mg Tablet, Film Coated | 4Non-Preferred Drug | 30% | N/A |
|
| EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 600/200/300 mg Tablet, Film Coated | 4Non-Preferred Drug | 30% | N/A |
|
| EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 400/300/300 mg Tablet, Film Coated | 5Specialty Tier | 25% | N/A |
|
| EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 600/300/300 mg Tablet, Film Coated | 5Specialty Tier | 25% | N/A |
|
| ELETRIPTAN HYDROBROMIDE 20 mg Tablet, Film Coated | 4Non-Preferred Drug | 30% | N/A |
|
| ELETRIPTAN HYDROBROMIDE 40 mg Tablet, Film Coated | 4Non-Preferred Drug | 30% | N/A |
|
| ELIGARD 45 mg/.375mL Injection, Suspension, Extended ReleaseLeuprolide Acetate | 4Non-Preferred Drug | 30% | N/A |
|
| ELIGARD KitLeuprolide Acetate | 4Non-Preferred Drug | 30% | N/A |
|
| ELIGARD KitLeuprolide Acetate | 4Non-Preferred Drug | 30% | N/A |
|
| ELIGARD KitLeuprolide Acetate | 4Non-Preferred Drug | 30% | N/A |
|
| ELIQUIS 2.5 mg Tablet, Film CoatedApixaban | 3Preferred Brand | 23% | 18% |
|
| ELIQUIS 30-DAY STARTER PACK KitApixaban | 3Preferred Brand | 23% | 18% |
|
| ELIQUIS 5 mg Tablet, Film CoatedApixaban | 3Preferred Brand | 23% | 18% |
|
| ELMIRON 100 mg Capsule, Gelatin CoatedPentosan Polysulfate Sodium | 4Non-Preferred Drug | 30% | N/A |
|
| ELURYNG .12/.015 mg/d RingEtonogestrel And Ethinyl Estradiol | 3Preferred Brand | 23% | 18% |
|
| EMGALITY 100 mg/mL Injection, SolutionGalcanezumab-Gnlm | 4Non-Preferred Drug | 30% | N/A |
|
| EMGALITY 120 mg/mL Injection, SolutionGalcanezumab-Gnlm | 4Non-Preferred Drug | 30% | N/A |
|
| EMGALITY 120 mg/mL Injection, SolutionGalcanezumab-Gnlm | 4Non-Preferred Drug | 30% | N/A |
|
| EMSAM 12 mg/24h PatchSelegiline | 5Specialty Tier | 25% | N/A |
|
| EMSAM 6 mg/24h PatchSelegiline | 5Specialty Tier | 25% | N/A |
|
| EMSAM 9 mg/24h PatchSelegiline | 5Specialty Tier | 25% | N/A |
|
| EMTRICITABINE 200 mg Capsule | 4Non-Preferred Drug | 30% | N/A |
|
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100/150 mg Tablet, Film Coated | 4Non-Preferred Drug | 30% | N/A |
|
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133/200 mg Tablet, Film Coated | 4Non-Preferred Drug | 30% | N/A |
|
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167/250 mg Tablet, Film Coated | 4Non-Preferred Drug | 30% | N/A |
|
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated | 4Non-Preferred Drug | 30% | N/A |
|
| EMTRICITABINE, RILPIVIRINE, TENOFOVIR DISOPROXIL FUMARATE 200/25/300 mg Tablet, Film Coated | 5Specialty Tier | 25% | N/A |
|
| EMTRIVA 10 mg/mL SolutionEmtricitabine | 4Non-Preferred Drug | 30% | N/A |
|
| ENALAPRIL MALEATE 10 mg Tablet | 2Generic | $3.00 | $0.00 | None |
| ENALAPRIL MALEATE 2.5 mg Tablet | 2Generic | $3.00 | $0.00 | None |
| ENALAPRIL MALEATE 20 mg Tablet | 2Generic | $3.00 | $0.00 | None |
| ENALAPRIL MALEATE 5 mg Tablet | 2Generic | $3.00 | $0.00 | None |
| ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE 10/25 mg Tablet | 2Generic | $3.00 | $0.00 | None |
| ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE 5/12.5 mg Tablet | 2Generic | $3.00 | $0.00 | None |
| ENBREL 25 mg/.5mL SolutionEtanercept | 5Specialty Tier | 25% | N/A |
|
| ENBREL 25 mg/.5mL SolutionEtanercept | 5Specialty Tier | 25% | N/A |
|
| ENBREL 50 mg/mL SolutionEtanercept | 5Specialty Tier | 25% | N/A |
|
| ENBREL 50 mg/mL SolutionEtanercept | 5Specialty Tier | 25% | N/A |
|
| ENBREL 50 mg/mL SolutionEtanercept | 5Specialty Tier | 25% | N/A |
|
| ENGERIX-B 10 ug/.5mL Injection, SuspensionHepatitis B Vaccine (Recombinant) | 1Preferred Generic | $2.00 | $0.00 |
|
| ENGERIX-B 20 ug/mL Injection, SuspensionHepatitis B Vaccine (Recombinant) | 1Preferred Generic | $2.00 | $0.00 |
|
| ENILLORING .015/.12 mg/d RingEtonogestrel And Ethinyl Estradiol Vaginal | 3Preferred Brand | 23% | 18% |
|
| ENOXAPARIN SODIUM 100 mg/mL Injection | 4Non-Preferred Drug | 30% | N/A | None |
| ENOXAPARIN SODIUM 100 mg/mL Injection | 4Non-Preferred Drug | 30% | N/A | None |
| ENOXAPARIN SODIUM 100 mg/mL Injection | 4Non-Preferred Drug | 30% | N/A | None |
| ENOXAPARIN SODIUM 100 mg/mL Injection | 4Non-Preferred Drug | 30% | N/A | None |
| ENOXAPARIN SODIUM 100 mg/mL Injection | 4Non-Preferred Drug | 30% | N/A | None |
| ENOXAPARIN SODIUM 150 mg/mL Injection | 4Non-Preferred Drug | 30% | N/A | None |
| ENOXAPARIN SODIUM 150 mg/mL Injection | 4Non-Preferred Drug | 30% | N/A | None |
| ENSACOVE 100 mg CapsuleEnsartinib | 5Specialty Tier | 25% | N/A |
|
| ENSACOVE 25 mg CapsuleEnsartinib | 5Specialty Tier | 25% | N/A |
|
| ENSKYCE KitDesogestrel And Ethinyl Estradiol | 3Preferred Brand | 23% | 18% | None |
| ENTACAPONE 200 mg Tablet | 3Preferred Brand | 23% | 18% |
|
| ENTECAVIR .5 mg Tablet | 4Non-Preferred Drug | 30% | N/A |
|
| ENTECAVIR 1 mg Tablet | 4Non-Preferred Drug | 30% | N/A |
|
| ENTRESTO 15/16 mg PelletSacubitril And Valsartan | 3Preferred Brand | 23% | 18% |
|
| ENTRESTO 6/6 mg PelletSacubitril And Valsartan | 3Preferred Brand | 23% | 18% |
|
| ENULOSE 10 g/15mL SolutionLactulose | 2Generic | $3.00 | $0.00 | None |
| ENVARSUS XR .75 mg Tablet, Extended ReleaseTacrolimus | 4Non-Preferred Drug | 30% | N/A |
|
| ENVARSUS XR 1 mg Tablet, Extended ReleaseTacrolimus | 4Non-Preferred Drug | 30% | N/A |
|
| ENVARSUS XR 4 mg Tablet, Extended ReleaseTacrolimus | 4Non-Preferred Drug | 30% | N/A |
|
| EPCLUSA 100/400 mg Tablet, Film CoatedVelpatasvir And Sofosbuvir | 5Specialty Tier | 25% | N/A |
|
| EPCLUSA 37.5/150 mg PelletVelpatasvir And Sofosbuvir | 5Specialty Tier | 25% | N/A |
|
| EPCLUSA 50/200 mg PelletVelpatasvir And Sofosbuvir | 5Specialty Tier | 25% | N/A |
|
| EPCLUSA 50/200 mg Tablet, Film CoatedVelpatasvir And Sofosbuvir | 5Specialty Tier | 25% | N/A |
|
| EPIDIOLEX 100 mg/mL SolutionCannabidiol | 5Specialty Tier | 25% | N/A |
|
| EPINEPHRINE .15 mg/.15mL Injection | 3Preferred Brand | 23% | 18% |
|
| EPINEPHRINE .15 mg/.3mL Injection | 3Preferred Brand | 23% | 18% |
|
| EPINEPHRINE .3 mg/.3mL Injection | 3Preferred Brand | 23% | 18% |
|
| EPINEPHRINE .3 mg/.3mL Injection | 3Preferred Brand | 23% | 18% |
|
| EPRONTIA 25 mg/mL SolutionTopiramate | 4Non-Preferred Drug | 30% | N/A |
|
| ERGOTAMINE TARTRATE AND CAFFEINE 1/100 mg Tablet, Film Coated | 3Preferred Brand | 23% | 18% |
|
| ERIVEDGE 150 mg CapsuleVismodegib | 5Specialty Tier | 25% | N/A |
|
| ERLEADA 240 mg Tablet, Film CoatedApalutamide | 5Specialty Tier | 25% | N/A |
|
| ERLEADA 60 mg Tablet, Film CoatedApalutamide | 5Specialty Tier | 25% | N/A |
|
| ERLOTINIB 100 mg Tablet, Film Coated | 5Specialty Tier | 25% | N/A |
|
| ERLOTINIB 150 mg Tablet, Film Coated | 5Specialty Tier | 25% | N/A |
|
| ERLOTINIB 25 mg Tablet | 5Specialty Tier | 25% | N/A |
|
| ERTAPENEM 1 g/20mL InjectionErtapenem Sodium | 4Non-Preferred Drug | 30% | N/A | None |
| ERYTHROCIN LACTOBIONATE 500 mg/10mL Injection, Powder, Lyophilized, For SolutionErythromycin Lactobionate | 4Non-Preferred Drug | 30% | N/A | None |
| ERYTHROMYCIN 20 mg/mL Solution | 4Non-Preferred Drug | 30% | N/A |
|
| ERYTHROMYCIN 250 mg Capsule, Delayed Release Pellets | 4Non-Preferred Drug | 30% | N/A | None |
| ERYTHROMYCIN 250 mg Tablet, Coated | 4Non-Preferred Drug | 30% | N/A | None |
| ERYTHROMYCIN 250 mg Tablet, Delayed Release | 4Non-Preferred Drug | 30% | N/A | None |
| ERYTHROMYCIN 333 mg Tablet, Delayed Release | 4Non-Preferred Drug | 30% | N/A | None |
| ERYTHROMYCIN 5 mg/g Ointment | 2Generic | $3.00 | $0.00 |
|
| ERYTHROMYCIN 500 mg Tablet, Coated | 4Non-Preferred Drug | 30% | N/A | None |
| ERYTHROMYCIN 500 mg Tablet, Delayed Release | 4Non-Preferred Drug | 30% | N/A | None |
| ESCITALOPRAM 10 mg Tablet, Film Coated | 2Generic | $3.00 | $0.00 | None |
| ESCITALOPRAM 15 mg Capsule | 4Non-Preferred Drug | 30% | N/A | None |
| ESCITALOPRAM 20 mg Tablet, Film Coated | 2Generic | $3.00 | $0.00 | None |
| ESCITALOPRAM 5 mg Tablet, Film Coated | 2Generic | $3.00 | $0.00 | None |
| ESCITALOPRAM OXALATE 5 mg/5mL SolutionEscitalopram | 4Non-Preferred Drug | 30% | N/A |
|
| ESLICARBAZEPINE ACETATE 200 mg Tablet | 4Non-Preferred Drug | 30% | N/A |
|
| ESLICARBAZEPINE ACETATE 400 mg Tablet | 4Non-Preferred Drug | 30% | N/A |
|
| ESLICARBAZEPINE ACETATE 600 mg Tablet | 4Non-Preferred Drug | 30% | N/A |
|
| ESLICARBAZEPINE ACETATE 800 mg Tablet | 4Non-Preferred Drug | 30% | N/A |
|
| ESTARYLLA KitNorgestimate And Ethinyl Estradiol | 3Preferred Brand | 23% | 18% | None |
| ESTRADIOL .025 mg/d Patch | 4Non-Preferred Drug | 30% | N/A |
|
| ESTRADIOL .025 mg/d Patch | 4Non-Preferred Drug | 30% | N/A |
|
| ESTRADIOL .0375 mg/d Patch | 4Non-Preferred Drug | 30% | N/A |
|
| ESTRADIOL .0375 mg/d Patch | 4Non-Preferred Drug | 30% | N/A |
|
| ESTRADIOL .05 mg/d Patch | 4Non-Preferred Drug | 30% | N/A |
|
| ESTRADIOL .05 mg/d Patch | 4Non-Preferred Drug | 30% | N/A |
|
| ESTRADIOL .06 mg/d Patch | 4Non-Preferred Drug | 30% | N/A |
|
| ESTRADIOL .075 mg/d Patch | 4Non-Preferred Drug | 30% | N/A |
|
| ESTRADIOL .075 mg/d Patch | 4Non-Preferred Drug | 30% | N/A |
|
| ESTRADIOL .1 mg/d Patch | 4Non-Preferred Drug | 30% | N/A |
|
| ESTRADIOL .1 mg/d Patch | 4Non-Preferred Drug | 30% | N/A |
|
| ESTRADIOL .5 mg Tablet | 2Generic | $3.00 | $0.00 | None |
| ESTRADIOL / NORETHINDRONE ACETATE .5/.1 mg Tablet, Film CoatedEstradiol And Norethindrone Acetate | 3Preferred Brand | 23% | 18% | None |
| ESTRADIOL / NORETHINDRONE ACETATE 1/.5 mg Tablet, Film CoatedEstradiol And Norethindrone Acetate | 3Preferred Brand | 23% | 18% | None |
| ESTRADIOL 1 mg Tablet | 2Generic | $3.00 | $0.00 | None |
| ESTRADIOL 2 mg Tablet | 2Generic | $3.00 | $0.00 | None |
| ESTRADIOL VAGINAL .1 mg/g CreamEstradiol | 3Preferred Brand | 23% | 18% | None |
| ESTRADIOL VALERATE 10 mg/mL Injection | 4Non-Preferred Drug | 30% | N/A | None |
| ESTRING 2 mg SystemEstradiol | 4Non-Preferred Drug | 30% | N/A |
|
| ETHAMBUTOL HYDROCHLORIDE 100 mg Tablet | 3Preferred Brand | 23% | 18% | None |
| ETHAMBUTOL HYDROCHLORIDE 400 mg Tablet | 3Preferred Brand | 23% | 18% | None |
| ETHOSUXIMIDE 250 mg/5mL Solution | 4Non-Preferred Drug | 30% | N/A | None |
| ETONOGESTREL/ETHINYL ESTRADIOL .12/.015 mg/d Insert, Extended ReleaseEtonogestrel And Ethinyl Estradiol | 3Preferred Brand | 23% | 18% |
|
| ETRAVIRINE 100 mg Tablet | 5Specialty Tier | 25% | N/A |
|
| ETRAVIRINE 200 mg Tablet | 5Specialty Tier | 25% | N/A |
|
| EULEXIN 125 mg CapsuleFlutamide | 5Specialty Tier | 25% | N/A |
|
| EVEROLIMUS .25 mg Tablet | 4Non-Preferred Drug | 30% | N/A |
|
| EVEROLIMUS .5 mg Tablet | 5Specialty Tier | 25% | N/A |
|
| EVEROLIMUS .75 mg Tablet | 5Specialty Tier | 25% | N/A |
|
| EVEROLIMUS 1 mg Tablet | 5Specialty Tier | 25% | N/A |
|
| EVEROLIMUS 10 mg Tablet | 5Specialty Tier | 25% | N/A |
|
| EVEROLIMUS 2 mg Tablet, For Suspension | 5Specialty Tier | 25% | N/A |
|
| EVEROLIMUS 2.5 mg Tablet | 5Specialty Tier | 25% | N/A |
|
| EVEROLIMUS 3 mg Tablet, For Suspension | 5Specialty Tier | 25% | N/A |
|
| EVEROLIMUS 5 mg Tablet | 5Specialty Tier | 25% | N/A |
|
| EVEROLIMUS 5 mg Tablet, For Suspension | 5Specialty Tier | 25% | N/A |
|
| EVEROLIMUS 7.5 mg Tablet | 5Specialty Tier | 25% | N/A |
|
| EVOTAZ 300/150 mg TabletAtazanavir And Cobicistat | 5Specialty Tier | 25% | N/A |
|
| EXEMESTANE 25 mg Tablet | 4Non-Preferred Drug | 30% | N/A |
|
| EXXUA 18.2 mg Tablet, Extended ReleaseGepirone | 5Specialty Tier | 25% | N/A |
|
| EXXUA 18.2 mg Tablet, Extended ReleaseGepirone | 5Specialty Tier | 25% | N/A |
|
| EXXUA 36.3 mg Tablet, Extended ReleaseGepirone | 5Specialty Tier | 25% | N/A |
|
| EXXUA 54.5 mg Tablet, Extended ReleaseGepirone | 5Specialty Tier | 25% | N/A |
|
| EXXUA 72.6 mg Tablet, Extended ReleaseGepirone | 5Specialty Tier | 25% | N/A |
|
| EZETIMIBE 10 mg Tablet | 3Preferred Brand | 23% | 18% |
|
| EZETIMIBE AND SIMVASTATIN 10/10 mg Tablet | 3Preferred Brand | 23% | 18% |
|
| EZETIMIBE AND SIMVASTATIN 10/20 mg Tablet | 3Preferred Brand | 23% | 18% |
|
| EZETIMIBE AND SIMVASTATIN 10/40 mg Tablet | 3Preferred Brand | 23% | 18% |
|
| EZETIMIBE AND SIMVASTATIN 10/80 mg Tablet | 3Preferred Brand | 23% | 18% |
|
PA = prior authorization, ST = step therapy, QL = quantity limit. Costs are the plan’s initial-coverage cost-sharing from the CMS 2026 formulary files; a drug not listed here is not on this plan’s formulary, though a formulary exception may still be possible.